Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) — Capital Reinvestment Ratio
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) has a Capital Reinvestment Ratio of 0.92x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥126.49 Million) in capital expenditures (CN¥115.96 Million). See Jiangsu Canopus Wisdom Medical Technolog (301290) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A Capital Reinvestment Ratio (2020–2024)
This chart tracks Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A's Capital Reinvestment Ratio across 5 annual periods. Check Jiangsu Canopus Wisdom Medical Technolog (301290) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (2020–2024)
Year-by-year Capital Reinvestment Ratio for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A from 2020 to 2024. For live market cap and broader valuation context, see Jiangsu Canopus Wisdom Medical Technolog market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.92x | CN¥126.49 Million | CN¥115.96 Million | ▲ +34.2% |
| 2023 | 0.68x | CN¥163.13 Million | CN¥111.46 Million | ▼ -13.0% |
| 2022 | 0.79x | CN¥94.63 Million | CN¥74.35 Million | ▲ +34.2% |
| 2021 | 0.59x | CN¥163.45 Million | CN¥95.67 Million | ▲ +162.6% |
| 2020 | 0.22x | CN¥114.07 Million | CN¥25.43 Million | — |